Investing in Longevity: How to Allocate Capital Toward the Health-Span Revolution
The multi-trillion-dollar longevity economy promises a future where ninety is the new sixty, shifting capital markets away from reactive elder care and toward preventative cellular maintenance. Yet, beneath the pitch decks of biotech startups and wearable ecosystems lies an aggressive financialization of human biology that risks turning basic wellness into an exclusive, surveillance-driven asset class. … Read more